BioSpace News Archive

Biotech Beach

Lineage Cell Therapeutics Joins Russell 3000® and Russell Microcap® Indexes

Lineage Cell Therapeutics Joins Russell 3000 ® and Russell Microcap ® Indexes

June 28, 2021
·
6 min read
BioCapital

Senseonics Announces Presentation of PROMISE Data at the American Diabetes Association 81st Scientific Sessions

Senseonics Holdings, Inc. today announced further presentation of PROMISE Study data evaluating the next generation Eversense CGM System at the American Diabetes Association Virtual 81st Annual Scientific Sessions.

June 28, 2021
·
3 min read
Business

Lengo Therapeutics Appoints Enoch K. Kariuki as Chief Executive Officer

Lengo Therapeutics today announced the appointment of Enoch K. Kariuki, Pharm.D., as Chief Executive Officer.

June 28, 2021
·
2 min read
Business

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and Bioeq AG (“Bioeq”) today announced that they have entered into a strategic partnership for the exclusive commercialization of Bioeq’s FYB201, a biosimilar candidate to Lucentis ®.

June 28, 2021
·
7 min read
Business

Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition

Agilent Technologies Inc. (NYSE: A) today announced the publication of a study carried out in partnership with Resolution Bioscience (a part of Agilent) and Dana-Farber Cancer Institute .

June 28, 2021
·
3 min read
Business

Kate Cronin to Join Moderna as Chief Brand Officer on July 12

Moderna , Inc. today announced that Kate Cronin will join Moderna as Chief Brand Officer effective Monday, July 12, 2021.

June 28, 2021
·
5 min read
Business

Cybin Inc. Releases Annual Financials and Provides Business Highlights

Cybin Inc. Releases Annual Financials and Provides Business Highlights

June 28, 2021
·
8 min read
Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement

Cybin Inc. is pleased to announce that Adelia Therapeutics Inc. (“ Adelia ”), a wholly-controlled subsidiary of Cybin, has achieved certain earn-out milestones for the period commencing January 1, 2021.

June 28, 2021
·
8 min read
Deals

Applied UV Announces Offering of Preferred Stock

Applied UV, Inc. announced the commencement of an underwritten public offering of its 10.5% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”).

June 28, 2021
·
5 min read
Biotech Bay

180 Life Sciences Joins Russell Microcap® Index

180 Life Sciences Corp. announced today that it has joined the Russell Microcap® Index, effective after the U.S. market opens today, June 28.

June 28, 2021
·
4 min read